Dr. Richard Lam, of Prostate Oncology Specialists, a double board-certified internist and oncologist who has dedicated his career to the specialized treatment of prostate cancer at Prostate Oncology Specialists since 2001.
Renowned for his expertise, Dr. Lam will delve into the latest advancements in prostate cancer, including cutting-edge treatments, emerging clinical trials, and groundbreaking research that are shaping the future of care. His ability to present complex medical information in a clear, accessible, and engaging manner makes his talks a must-attend for anyone seeking the most up-to-date knowledge in the field.
Beyond his depth of knowledge, Dr. Lam’s presentations are known for their wit and humor, ensuring an informative and enjoyable experience. Don’t miss this opportunity to hear from one of the leading voices in prostate oncology!
In "Episode 2" of the series on "Present and future of diagnostics in prostate cancer," Prof. Monique Roobol (NL) and Dr. Tamás Fazekas (HU) review the ongoing debate surrounding prostate cancer screening.
They review the history and development of screening strategies, including the key findings from early trials and the progression toward more personalised, risk-stratified approaches.
Prof. Roobol discusses the significance of PSA testing and how it serves as a tool for initial risk stratification, while also addressing...
* the truisms are that most men die with rather than of prostate cancer, if you live long enough almost all men will get a couple of cancer cells in the prostate
Dr. Matthew Cooperberg takes us on a candid journey through Active Surveillance for prostate cancer—starting with its earliest days in the 1990s, through the ups and downs of PSA screening and treatment trends, and into today’s era of MRI, genomic tests, and AI-guided risk assessment.
This presentation is particularly exceptional, delivered as Dr. Cooperberg...
